Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative.
Despite the many proposed advantages related to nanotechnology, there are increasing concerns as to the potential adverse human health and environmental effects that the production of, and subsequent exposure to nanoparticles (NPs) might pose. In regard to human health, these concerns are founded upon the plethora of knowledge gained from research relating to the effects observed following exposure to environmental air pollution. It is known that increased exposure to environmental air pollution can cause reduced respiratory health, as well as exacerbate pre-existing conditions such as cardiovascular disease and chronic obstructive pulmonary disease. Such disease states have also been associated with exposure to the NP component contained within environmental air pollution, raising concerns as to the effects of NP exposure. It is not only exposure to accidentally produced NPs however, which should be approached with caution. Over the past decades, NPs have been specifically engineered for a wide range of consumer, industrial and technological applications. Due to the inevitable exposure of NPs to humans, owing to their use in such applications, it is therefore imperative that an understanding of how NPs interact with the human body is gained. In vivo research poses a beneficial model for gaining immediate and direct knowledge of human exposure to such xenobiotics. This research outlook however, has numerous limitations. Increased research using in vitro models has therefore been performed, as these models provide an inexpensive and high-throughput alternative to in vivo research strategies. Despite such advantages, there are also various restrictions in regard to in vitro research. Therefore, the aim of this review, in addition to providing a short perspective upon the field of nanotoxicology, is to discuss (1) the advantages and disadvantages of in vitro research and (2) how in vitro research may provide essential information pertaining to the human health risks posed by NP exposure.
Clift
Martin J D
MJ
Institute of Anatomy, Division of Histology, University of Bern, Bern, Switzerland. martin.clift@ana.unibe.ch
Gehr
Peter
P
Rothen-Rutishauser
Barbara
B
D000393:Air Pollutants / Q000633:toxicity; D000826:Animal Testing Alternatives; D000818:Animals; D002478:Cells, Cultured; D003584:Cytological Techniques; D006801:Humans; D008422:Materials Testing; D053758:Nanoparticles / Q000633:toxicity*; D036103:Nanotechnology / Q000639:trends; D015203:Reproducibility of Results; D018675:Toxicity Tests / Q000639:trends
D000393:Air Pollutants